Fecal Microbiota Transplantation Database (FMTdb) -1

This study introduces the Fecal Microbiota Transplantation Database (FMTdb), a pioneering resource developed to enhance our understanding of fecal microbiota transplantation (FMT) and its role in treating gastrointestinal disorders, especially refractory Clostridium difficile infections. The FMTdb brings together extensive data from a diverse range of participants, including community individuals, FMT donors, and recipients, creating a rich platform for investigating the gut microbiome's influence on human health.Our approach involved meticulous donor selection and recipient enrollment processes, along with detailed data collection. Donors were rigorously screened medically, and their fecal samples were analyzed for microbial composition. Recipients, chosen for their various gastrointestinal ailments, underwent microbial fluid transplants. The outcomes and clinical indicators of these procedures were closely monitored and fed into the FMTdb. This database, equipped with advanced bioinformatics tools, allows for an in-depth examination of gut microbiota dynamics and their implications.A key finding from our research is the notable variability in FMT's effectiveness, highlighting the necessity of personalized treatment plans. By analyzing donor and recipient microbiota, the FMTdb provides critical insights into treatment outcomes and potential therapeutic targets, including the influence of gut microbiota on immune modulation. This can have far-reaching implications for immune-related disorders.The FMTdb is not just a repository of data; it is an analytical tool that offers targeted search options, comprehensive browsing, and data visualization features. Our study underscores the importance of considering both donor and recipient characteristics in FMT and advocates for customized treatment approaches. The FMTdb represents a significant stride forward in microbiota research, offering valuable insights into the complexities and potential of FMT, thereby contributing substantially to scientific discourse and clinical progress in the field of microbiota transplantation.This release represents the first part of our data, encompassing 500 samples of 16S rRNA v4 sequencing.

本研究介绍了粪便菌群移植数据库（Fecal Microbiota Transplantation Database, FMTdb），这一开创性资源旨在加深我们对粪便菌群移植（Fecal Microbiota Transplantation, FMT）及其在治疗胃肠道疾病，尤其是难治性艰难梭菌感染（Clostridium difficile infections）中的作用的理解。FMTdb整合了来自社区个体、粪便菌群移植供者与受者等多样化群体的海量数据，为探究肠道菌群对人类健康的影响搭建了丰富的研究平台。本研究采用了严谨的供者筛选与受者入组流程，并辅以精细化的数据采集工作。供者需经过严格的医学筛查，其粪便样本的微生物组成均得到全面分析。入组受者均罹患各类胃肠道疾病，并接受了微生物菌群移植。研究团队对该操作的结局与临床指标进行了密切监测，并将相关数据录入FMTdb。该数据库配备先进的生物信息学工具，可用于深入解析肠道菌群的动态变化及其潜在影响。本研究的一项核心发现为粪便菌群移植的疗效存在显著异质性，这凸显了制定个性化治疗方案的必要性。通过分析供者与受者的菌群特征，FMTdb可为治疗结局及潜在治疗靶点提供关键见解，包括肠道菌群对免疫调节的影响，这一发现对免疫相关疾病的研究具有深远意义。FMTdb不仅是数据存储库，更是一款具备定向检索、全面浏览与数据可视化功能的分析工具。本研究强调了在粪便菌群移植中同时考量供者与受者特征的重要性，并倡导采用定制化的治疗策略。FMTdb标志着菌群研究领域的重要进展，为阐明粪便菌群移植的复杂性与应用潜力，从而为菌群移植领域的学术探讨与临床进步提供了重要支撑。本次发布为本研究数据集的第一部分，涵盖500份16S rRNA v4测序（16S rRNA v4 sequencing）样本。